Phio Pharmaceuticals Corp. held its Annual Meeting of Stockholders on September 11, 2025. During the meeting, several key proposals were voted on and approved by the stockholders. The election of six directors was confirmed. The appointment of Grant Thornton, LLP as the company's independent registered public accounting firm for the year ending December 31, 2025, was ratified. An amendment and restatement of the 2020 Long Term Incentive Plan, which increased the number of shares of common stock available for issuance, was approved. Additionally, a non-binding advisory vote approved "3 years" as the preferred frequency for future advisory votes on the compensation of the company's named executive officers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-006985), on September 15, 2025, and is solely responsible for the information contained therein.
Comments